Literature DB >> 12690726

Overview of social inequalities in health in the region of the Americas, using various methodological approaches.

George A O Alleyne1, Carlos Castillo-Salgado, Maria Cristina Schneider, Enrique Loyola, Manuel Vidaurre.   

Abstract

Over the past decade, according to several important indicators, health conditions have improved in the Region of the Americas. However, inequalities persist among the countries of the Region. This article has two primary objectives: 1) to provide some unbiased evidence on health inequalities among countries of the Region of the Americas and 2) to illustrate the application of some of the more frequently used methods for measuring inequalities, including effect measurements, population attributable risk, the slope index of inequality, the relative index of inequality, and the concentration index. Analyses have shown that there are great health disparities in the Region of the Americas. For example, residents of the poorest countries of the Region live nearly 10 years less, on average, than do residents of the richest countries. If the other countries of the Americas had the same incidence of tuberculosis as does the subregion of North America (Bermuda, Canada, and the United States of America), there would be 76% fewer cases of this disease in the Region. In the Americas, nearly 35% of deaths of infants under 1 year old are concentrated in the 20% of live births that occur in the group with the lowest income. As for maternal mortality in the Americas, fewer than 2% of maternal deaths occur in association with the 20% of live births in the group with the highest income. The analyses of health inequalities based on the use of various methods highlight the existence of important disparities among subregions and countries of the Americas that are not readily seen when using only the more-traditional methods for analyzing mortality and morbidity. There is also a need to incorporate the concepts of distribution and socioeconomic dimensions of health when interpreting a given situation. Using this approach will allow decisionmakers to target areas and populations that are in less-favorable conditions. A considerable body of aggregate data at the Regional and country levels from routine information systems is already available--especially on morbidity, mortality, and other health-related factors--that can be used on a regular basis to analyze health inequalities. These kinds of analyses may be regarded as a first step toward the identification of health inequities.

Entities:  

Mesh:

Year:  2002        PMID: 12690726     DOI: 10.1590/s1020-49892002001200005

Source DB:  PubMed          Journal:  Rev Panam Salud Publica        ISSN: 1020-4989


  5 in total

1.  Disparidad en Salud: Un Fenómeno Multidimensional.

Authors:  Maria-Teresa Urrutia; Rosina Cianelli
Journal:  Hisp Health Care Int       Date:  2010-03-01

2.  The impact of primary healthcare in reducing inequalities in child health outcomes, Bogotá-Colombia: an ecological analysis.

Authors:  Paola A Mosquera; Jinneth Hernández; Román Vega; Jorge Martínez; Ronald Labonte; David Sanders; Miguel San Sebastián
Journal:  Int J Equity Health       Date:  2012-11-13

Review 3.  Noncommunicable diseases and injuries in Latin America and the Caribbean: time for action.

Authors:  Pablo Perel; Juan P Casas; Zulma Ortiz; J Jaime Miranda
Journal:  PLoS Med       Date:  2006-09       Impact factor: 11.069

4.  Inequalities in full vaccination coverage based on maternal education and wealth quintiles among children aged 12-23 months: further analysis of national cross-sectional surveys of six South Asian countries.

Authors:  Kiran Acharya; Dinesh Dharel; Raj Kumar Subedi; Asmita Bhattarai; Yuba Raj Paudel
Journal:  BMJ Open       Date:  2022-02-07       Impact factor: 2.692

5.  Social inequalities in healthcare utilization during Ecuadorian healthcare reform (2007-2017): a before-and-after cross-sectional study.

Authors:  Edy Quizhpe; Enrique Teran; Anni-Maria Pulkki-Brännström; Miguel San Sebastián
Journal:  BMC Public Health       Date:  2022-03-14       Impact factor: 3.295

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.